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 50% of survivors of severe neonatal HIE developed epilepsy by age 1 year 
 Poor neonatal neurophysiology and MRI predict infantile onset epilepsy after HIE 






To evaluate the accuracy of hypoxic ischemic encephalopathy (HIE) grade, and neonatal 
neurophysiological and neuroimaging measures for predicting development of infantile 
spasms syndrome (IS) or other postneonatal, infantile onset epilepsy after perinatal HIE. 
 
Methods 
We examined a population-based cohort of 92 consequent infants with moderate-to-severe 
HIE. The HIE grade and neonatal neuroimaging (MRI) and neurophysiology (EEG and 
somatosensory evoked potentials, SEPs) findings were compared to the development of IS or 
other epilepsy within the first year of life. 
 
Results 
Out of 74 surviving infants with follow-up information, five developed IS and one developed 
a focal onset epilepsy. They all had recovered from severe HIE. All survivors with inactive 
neonatal EEG (recorded within the first few postnatal days, n=4) or the most severe type of 
brain injury in MRI (n=3) developed epilepsy (positive predictive value, PPV 100%). 





absent SEPs and a poor MRI finding (combined deep and cortical gray matter injury) resulted 
in higher PPV (86%) without lowering sensitivity (100%). Follow-up EEGs showed recurrent 
epileptiform activity already between 1- and 2-months age in those that developed epilepsy, 
distinguishing them from those surviving without epilepsy. 
 
Conclusions 
Poor neonatal neuroimaging and neurophysiological findings provide accurate prediction for 
development of infantile onset epilepsy after HIE. Of the neonates with severe HIE, the ones 
with severe neonatal MRI and neurophysiological abnormalities need frequent follow-up, 
including repeated EEGs, for early detection of IS. 
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Hypoxic-ischemic encephalopathy (HIE) due to perinatal asphyxia occurs in approximately 
2,5 per 1000 live full-term births1, and is one of the leading causes of neonatal deaths and 
severe developmental and neurological compromise2. HIE is also one of the most common 
causes of infantile spasms syndrome (IS)3 accounting for 8-10% of all IS cases4,5. HIE is 
currently treated with therapeutic hypothermia, which despite its favorable effect on the 
overall outcome, does not affect the rate of postneonatal epilepsy6–8 or IS9. Prediction of later 
epilepsy after perinatal HIE is, however, not straightforward, because the incidence of 
epilepsy may range from 0 to 100%, depending on the severity of HIE and/or the cohort 
being studied9–12. Yet, early diagnosis and control of IS are considered the key to a better 
prognosis13–15.  
 
In search for early diagnosis, several recent studies have attempted to identify predictive 
markers of later development of IS or other early onset epilepsies. Prior studies show that IS 
is associated with wide-spread structural abnormalities seen in magnetic resonance images 
(MRI)12,16, or with a prolonged depression of cortical activity seen in the 
electroencephalogram (EEG)17. The only available study in consecutive cooled neonates 
showed a clear correlation between the severity of injury in MRI and the probability of 
developing IS, but could not unambiguously identify all infants that were to develop IS12.  
 
Recent works from our18 and other centers19 have supported the intuitively acceptable notion 
that a combination of early structural (MRI) and functional (neurophysiology) measures may 
provide better prediction of outcomes than either method alone. Here, we set out to study in a 
population-based cohort whether onset of IS or other epilepsy during the first year of life 





days of life by combining information available from the routinely available clinical, 
neuroimaging and neurophysiological measures. Precise individual level prediction of which 
neonates will develop IS after HIE would not only enable earlier diagnosis and treatment, but 
also attempts to prevent IS, which could have beneficial effects on the neurodevelopment of 
these infants. 
 
PATIENTS AND METHODS 
Patients (Table 1) 
We first identified all neonates (n=100; 48 females) that were born at >36 gestational weeks 
and were treated for moderate or severe HIE at the Helsinki University Hospital between 
January 2011 and December 2016. We chose the 36-weeks gestational age limit based on 
previous publications on perinatal HIE6. An experienced neonatologist (MM) reviewed each 
newborn’s medical records to determine the HIE grade20 according to the the worst situation 
during the first four days of life. The Helsinki University Hospital is the only tertiary level 
referral center providing therapeutic hypothermia in the specific catchment area of Helsinki 
and Uusimaa, and hence the study cohort represents a birth cohort of N=122 647 during the 
six-year study period from 2011 to 2016.21 
 
Initial exclusion criteria were diagnosed or suspected genetic abnormalities, inborn errors of 
metabolism, or major anatomical malformations. Further eight infants were excluded due to 
absent EEG and/or MRI information, resulting in the final study group of 92 neonates. 
Institutional Research Review Board at Helsinki Children’s Hospital approved the study, 
including waiver of consent due to the retrospective and observational nature of the study. 






Of the 92 neonates, 76 received whole-body therapeutic hypothermia (target temperature 33-
34 degrees Celsius) for 72 hours as part of their treatment strategy. Cooling was initiated 
according to the criteria of the TOBY trial24. Cooling was initiated without a preceding 
amplitude-integrated EEG (aEEG) recording if aEEG was not available at the moment. 
Sixteen neonates did not fulfill the criteria for cooling. The neonates received antiepileptic 
drugs according to hospital protocols for seizures detected in aEEG monitoring. Antiepileptic 
drugs used in the neonatal period were discontinued after seizure control or at discharge in all 
but one newborn. 
 
Decisions on withdrawal of treatment 
Decisions to withdraw intensive care were based on a combination of poor clinical condition 
including severe HIE, poor EEG, and severe MRI findings. Decisions were made after 
discussions with parents. 
 
Neonatal neurophysiological recording  
All neurophysiological and neuroimaging studies were performed according to hospital 
guidelines. The neonatal EEG and somatosensory evoked potentials (SEPs) were recorded 
according to clinical need at a median age of 82 hours (IQR 58 hours) following our in-house 
developed clinical routines18,25,26. We collected the EEG and SEP signals at 2000 Hz using 
the NicoletOne EEG system (Cardinal Healthcare/Natus, USA; acquisition bandwidth 0.053 
to 500 Hz), Cz reference, and 21 channel EEG caps (sintered Ag/AgCl electrodes; 
Waveguard, ANT-Neuro, Germany). An additional electrode over the C7 vertebra detected 
the cervical SEP. The length of the recording (73 min ± 25 min) was determined by clinical 
need. We stimulated each median nerve at the wrist at 0.5 (n=27) or 1 Hz (n=64) rates using 





(Micromed Energy Light stimulator; Micromed, Italy) and pulse width of 0.2 ms. If standard 
stimulation was not possible due to intra-arterial lines, we stimulated the median nerve at the 
palm or elbow. The stimulation current was individually adjusted to just above the motor 
threshold. Two neonates only underwent unilateral median nerve stimulation because of 
Erb’s paresis on the other side. Four neonates did not undergo SEPs. 
 
Neonatal EEG background grading 
Two EEG experts (PN and VM) blinded to the clinical information (except the gestational 
and postnatal ages) independently scored all neonatal EEGs for background pattern. In case 
of disagreement, a third expert (LL) scored the given data, and the final score was reached by 
consensus. The neonatal EEG scores were modified18 from previously described criteria27: 
grade 4 = inactive trace (background activity <10 μV or severe discontinuity with interburst 
interval (IBI) > 60 s), grade 3 = severe abnormality (discontinuous activity with IBI 10 — 60 
s, severe attenuation of background patterns, no sleep-wake cycle), grade 2 = moderate 
abnormality (sleep-wake cycling present, discontinuous activity in quiet sleep with IBI <10 s, 
or clear asymmetry or asynchrony), grade 1 = mild abnormality (continuous activity with 
slightly abnormal activity: e.g., mild asymmetry, or mild voltage depression), and grade 0 = 
normal.  
 
Analysis of SEPs 
As described in detail before18,23,26, we averaged the neonatal EEG-SEPs offline in BESA® 
software (BESA GmbH, Germany) for epochs from –100 to 800 ms relative to stimulus onset 
without further filtering. An experienced clinical neurophysiologist (PN) blinded to the 
clinical information visually evaluated all SEPs using bipolar montages and electrical field 





neurophysiologist (LL) evaluated the given SEPs and consensus was reached through 
discussion.  
 
Cervical SEP was identified in the neck electrode (C7, referenced to Fz) between 8 and 20 
ms. Cortical SEP was observed as a salient response beginning within 100 ms from the 
stimulation in the contralateral centroparietal area coupled with a topographic pattern of 
electrical field that indicated a source at the contralateral primary somatosensory cortex i.e. a 
parietal negativity paired with a frontal positivity. SEPs were classified as bilaterally absent, 
unilaterally absent, or bilaterally present. 
 
Follow-up EEGs  
The follow-up EEGs were done according to clinical need at variable time points between 1-
month and 1-year ages. We only included follow-up EEGs recorded at >44 weeks 
postmenstrual age. In the follow-up recordings, the EEG signals were collected at 250 Hz 
using Cz reference and 19 electrodes placed according to the international 10-20 system 
(NicoletOne EEG system, Cardinal Healthcare/Natus, USA). Two experienced clinical 
neurophysiologists (PN and LL) reviewed the follow-up EEGs (and videos of suspected 
seizures) and classified them according to the following criteria developed by the authors and 
based on their clinical experience and previous studies28-30: Score 3) IS: defined as 
hypsarythmia with or without a typical series of infantile spasms, or modified hypsarythmia 
or multiple independent spikes with a typical series of infantile spasms; Score 2) recurrent 
epileptiform activity defined as three or more 30-s episodes during sleep with i) ≥ 5 
epileptiform discharges from at least two foci or ii) ≥ 10 epileptiform discharges from one 





As response to treatment was beyond the scope of this study, we did not review further 
follow-up EEGs performed after an EEG that was diagnostic of IS (Score 3).  
 
Magnetic resonance imaging (MRI) 
All 92 neonates of the final study group underwent brain MRI with a 1.5Tesla scanner (89 
neonates; Philips Intera Achieva, Philips Medical Systems, Best, The Netherlands) or a 
3Tesla scanner (3 neonates; Siemens Magnetom Skyra, Siemens Healthcare GmbH, 
Erlangen, Germany) between 1 and 16 days age (median 5 days). The imaging protocol 
included T1-weighted axial, T2-weighted axial and coronal, and diffusion weighted axial 
images. An experienced pediatric neuroradiologist (author STS) blinded to the clinical 
information classified the MRIs into six categories according to previously published 
criteria31. Score 0 = normal. 1A = minimal cerebral lesions. 1B = more extensive cerebral 
lesions alone (no involvement of basal ganglia, thalamus or anterior or posterior limb of the 
internal capsule, and no area of watershed infarction). 2A = any involvement of the basal 
ganglia, thalamus, anterior or posterior limb of the internal capsule or watershed infarction 




The primary outcome measure was diagnosis of IS within the first year of life, and the 
secondary outcome measure was diagnosis of any epilepsy within the first year of life. The 
outcomes were determined by retrospective review of the medical records from follow-up 
visits to a neuropediatrician and re-review of follow-up EEGs when available (see paragraph 
2.7.). As the follow-up visits were part of standard care, the neuropediatricians had access to 







We performed the statistical analysis with IBM SPSS Statistics software v. 23 (SPSS Inc, 
Chicago, IL, USA). We used the X2 test or Fisher’s exact test to compare the expected and 
observed frequencies. For between-groups comparisons we used one-way ANOVA, Mann-
Whitney U test, or Kruskal-Wallis test depending on the number of groups and type 
(continuous vs. ordinal) of the data. Normality of continuous data was tested with 
Kolmogorov-Smirnov-test. For level of statistical significance, we chose p < 0.05. Finally, 
we calculated the accuracy, sensitivity, specificity, and positive (PPV) and negative 
predictive values (NPV), including 95% confidence intervals, for the prespecified clinical, 
neurophysiological and neuroimaging findings and their combinations to predict development 
of IS or other epilepsy within the first year of life. 
 
RESULTS  
Of the 92 included neonates, six were lost to follow-up and 12 died in the neonatal period 
(Figure 1, Table 1 and 2), leaving 74 survivors in the final analysis. Five of them (7%) 
developed IS (at a mean age of 3.8 months (SD 1.0 month), range 2- and 4.5 months), and 
one (1%) developed focal onset epilepsy (at 5-months age) within the one-year follow-up 
period. There were no significant group differences in the baseline characteristics between 
the neonates that developed epilepsy and those that survived without epilepsy (Table 1). 
However, the infant that developed focal onset epilepsy was the only one on antiepileptic 
drugs (levetiracetam) continuously from the neonatal period onwards. 
 
Severe HIE, absence of SEPs, poor EEG and MRI scores were all significantly associated 





the sensitivity, specificity, PPV, and NPV of different clinical, neurophysiological and 
neuroimaging parameters and their combinations for predicting the development of IS or 
other epilepsy within the first year of life. All the six neonates that developed epilepsy had 
severe HIE (more details in Table 4). Of the individual neurophysiological and neuroimaging 
markers, the overall accuracy was highest (97%) for inactive EEG (sensitivity 67%, PPV 
100%) and bilaterally absent SEPs (sensitivity 100%, PPV 75%). When combined with 
severe HIE, the basal ganglia/thalamic and cortical injury in MRI (grades 2B and 3) also had 
97% accuracy, 100% sensitivity and 75% PPV. Of all combinations, the accuracy was 
highest for bilaterally absent SEPs and simultaneous combined basal ganglia/thalamic and 
cortical injury in MRI (six out of seven developed epilepsy: accuracy 98%, sensitivity 100%, 
PPV 86%). 
 
Follow-up EEGs between 2-weeks and 1-year age were available for a re-review in 9/12 
infants with severe HIE (five of the six that developed epilepsy) and 25/62 with moderate 
HIE (median 2 recordings per infant, range 1 – 4; mean postnatal age at the earliest follow-up 
EEG 3.1 months, SD 1.5 months; Figure 2). The EEG did not normalize at any point in any 
of the infants that developed IS or focal onset epilepsy during infancy. In the infants that 
developed IS, the EEGs acquired after the neonatal period but within the first two months all 
already showed recurrent epileptiform activity (score 2). Likewise, all infants with such EEG 
finding between one- and two-months age developed epilepsy. By 2 to 5 months, the EEGs of 
these infants already showed findings diagnostic of IS (score 3). The infant with focal onset 
epilepsy did not undergo an EEG between 2- and 8-months age, but at 2- and 8-months age 
the EEG showed recurrent epileptiform activity (score 2, multifocal). On the contrary, in 





early on; Only one of such infants had recurrent epileptiform activity (score 2) in his/her 
second follow-up EEG at 5-months age (Figure 2). 
 
DISCUSSION 
Our data show that HIE grade, neonatal MRI and neurophysiological findings and their 
combinations are all useful for evaluating which newborns affected by perinatal HIE will 
develop IS or other early postneonatal epilepsy. Recurrent epileptiform activity in follow-up 
EEGs during the first two postnatal months also distinguished those developing early 
epilepsy from those surviving the first year without epilepsy. 
 
Incidence of IS and postneonatal epilepsy after moderate-to-severe HIE 
In general concordance with recent literature on moderate-to-severe perinatal HIE, we found 
an overall incidence of 7% for IS (vs. 10%9) and 8% for any postneonatal epilepsy within the 
first year of life (vs. 6%32). Our study also clearly showed a distinction in the incidence of 
postneonatal epilepsy between neonates with moderate (0%) vs. severe (50%) HIE similar to 
prehypothermia era studies (moderate HIE 0-7% vs. severe HIE 60-100%)10,11 and one study 
including both TH and normothermia treated neonates (moderate HIE 2% vs. severe HIE 
20%).33 
 
Neonatal MRI in prediction of IS after moderate-to-severe perinatal HIE 
Previous studies showed that the combination of basal ganglia/thalamic and cortical injury, or 
total brain injury in MRI are associated with IS12,16, whereas cortical injury without 
subcortical gray matter injury is associated with a low risk for short-term postneonatal 
epilepsy12. Our results from a population-based cohort are in full agreement with these 





epilepsy had either total brain injury including cortical and subcortical structures (MRI score 
3) or basal ganglia/thalamic injury with associated cortical injury (MRI score 2B). 
Particularly, total brain injury seems to be highly predictive of epilepsy as all neonates with 
such finding developed early onset epilepsy in the present study as well as a previous study.12 
 
Neonatal neurophysiology in prediction of IS after moderate-to-severe perinatal HIE 
There is surprisingly little information on the predictive value of neonatal neurophysiological 
examinations to predict epilepsy after HIE. One small study showed in a selected cohort of 
17 neonates treated at normothermia that prolonged EEG depression was predictive of IS17. 
Our study in a large, population-based cohort significantly extends these findings by showing 
that an inactive EEG background within the first few days was associated with postneonatal 
infantile onset epilepsy in all four survivors, and that bilaterally absent SEPs were able to 
depict all the six neonates that developed epilepsy with only two false positives. The high 
specificity of an inactive EEG for early epilepsy must be considered cautiously, however, as 
some of the EEGs in our study were recorded within the first two days of life. In general, a 
poor EEG/aEEG is only considered to be predictive of a poor outcome (usually defined as 
death, severe motor or cognitive disability, or severe epilepsy) if it fails to recover within the 
first postnatal day in normothermia treated27 or within 36-48 hours in hypothermia treated 
newborns19,34–37. In our previous study, however, all newborns with an inactive EEG and 
bilaterally absent SEPs had a poor outcome even if the recordings were done within the first 
48 hours after birth.18 Hence, we suggest that the findings of the present study are interpreted 
so that an inactive neonatal EEG is highly predictive of infantile onset epilepsy at least when 






A previous study found neonatal status epilepticus to be an independent risk factor for 
postneonatal epilepsy33, whereas in another study neonatal seizures did not retain significant 
association with IS after adjusting for HIE severity (mild vs. moderate-to-severe9). We 
decided not to evaluate the possible effect of neonatal seizures or status epilepticus, as the 
EEGs included in our study were of a relatively short duration (mean 73 min), which would 
not give a truthful estimation of the seizure burden. 
 
Value of combining different neonatal predictors 
To our knowledge, only one study has combined neonatal clinical, neurophysiological and 
neuroimaging findings to predict development of epilepsy in TH treated neonates with HIE.38 
They identified pH<6.8, burst-suppression EEG at 72 h, and deep gray matter injury in MRI 
as predictive factors for later epilepsy and showed that the more predictive factors a patient 
had the higher was the risk for developing epilepsy. They, however, extracted the tested 
features from medical charts instead of using well-defined and replicable classification 
systems of EEG and MRI, thus limiting the parameters that could be tested. They also did not 
consider IS as a separate entity. When using our classification systems, both 
neurophysiological and imaging findings were accurate predictors of early epilepsy in 
neonates with severe HIE, and combining them resulted in correct negative prediction in only 
one more patient. Hence, at least when combined with HIE grade either method 
(neurophysiology or neuroimaging) is probably sufficient to identify the neonates at greatest 
risk for early epilepsy that require more intensive follow-up. 
 
EEG evolution towards IS 
To evaluate whether follow-up EEGs could be useful for identifying the infants developing 





experience as well as the few previous studies28-30 available. We chose multifocal/focal 
spiking as the criteria for Score 2 instead of modified hypsarythmia -level findings29 to catch 
the highest-risk infants as early as possible, since the latency from the first EEG changes to 
spasms may be very short, especially in HIE infants.28 In the infants that developed early 
postneonatal epilepsy, the initially highly abnormal EEGs never normalized completely after 
the neonatal period. Instead, all of these infants had recurrent epileptiform activity already in 
the earliest follow-up recordings between 1 and 2 months, followed by findings diagnostic of 
IS between 2 and 5 months. Importantly, recurrent epileptiform activity (score 2) was only 
seen in one of the infants surviving without epilepsy indicating that the proposed criteria 
could be useful for HIE follow-up as they were both sensitive and specific.  
 
Comparing to earlier studies is not straightforward as there is no unified system for the EEG 
scoring. Still, our results seem to be highly concordant with previous studies28,39 reporting 
that the EEGs of those HIE neonates that later developed IS, continued to have background 
abnormalities (e.g. discontinuity in quiet sleep) at age 1–2 months, and then multifocal 
discharges at 2–3 months, followed by hypsarrhythmia most frequently at 4–5 months. As the 
interval between appearance of spikes and hypsarrhythmia may be short28,39, the neonates at 
greatest risk of IS based on neonatal neurophysiology/neuroimaging need frequent EEG 
follow-ups to enable early diagnosis and treatment of IS. 
 
Limitations and strengths of the study 
Though our data was collected from a relatively large tertiary level university hospital over 
six years, the study includes a fairly low number of neonates with HIE that eventually 
developed IS or other epilepsy. The incidences of IS and epilepsy are, however, comparable 





that developed epilepsy also resulted in somewhat large confidence intervals for the 
predictive values. Hence, future studies are necessary to confirm our findings in larger 
populations. Furthermore, as all examinations were done according to clinical need, there was 
variation in the timing of the neonatal tests and follow-up EEGs, and number of follow-up 
EEGs. Despite these limitations, however, we were able to detect very robust predictive 
markers for infantile onset epilepsy.  
 
Strengths of our study are that it is population based and hence represents the whole spectrum 
of neonates with moderate-to-severe HIE, and as most of the newborns had their neurological 
and neurophysiological follow-up at our institution, we were able to determine their 




We demonstrate in a consequent, population-based cohort that amongst the neonates with 
severe HIE, those that will develop IS or other postneonatal epilepsy within the first year of 
life can be fairly accurately identified at individual level already in the neonatal period using 
neurophysiological and/or neuroimaging methods. Follow-up EEGs during the first few 
postnatal months further help to distinguish those developing towards early postneonatal 
epilepsy from those surviving the first year without epilepsy. Our results help in informing 
parents and in planning follow-ups for neonates with HIE. Importantly, IS started before the 
age of 5 months in all the five affected infants. Hence, frequent follow-ups including repeated 
EEGs are warranted particularly during the first months of life for those at highest risk. The 
present results also provide a foundation for studies investigating possibilities of preventing 
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Figure 1. Flow diagram of study inclusions. FU = follow-up. 
 
 
Figure 2. Follow-up EEG results. Each newborn is represented on the y-axis, and the x-axis 
indicates the timing of the follow-up EEGs. As the EEGs were done based on clinical need, 
their timing and number per infant is variable. Most infants had their first follow-up EEG 
within 6 months: ten infants had an EEG already before 2-months age (mean 1.6 months, SD 
0.2 months), and 22 infants had their first EEG between 2- and 6-months age (mean 3,4 
months, SD 0.8 months). Only two infants had their first EEG after 6 months (at 6.8- and 7.8-
months age). The colors depict the EEG findings. Black = findings diagnostic of infantile 
spasms syndrome (IS i.e. score 3), gray = recurrent epileptiform activity (i.e. score 2), white 
= not fulfilling either of the prior criteria (i.e. score 1). For a thorough explanation of the 





this study, we did not review the follow-up EEGs performed after an EEG that was 








Table 1. Baseline characteristics of the study population.  
Data shown as n (%), mean [SD], or median {IQR}. There were no significant differences 
between the different outcome groups in sex, TH treatment (Chi square), GA, birth weight, 
BE or pH (ANOVA). *Postnatal ages at EEG-SEP (p = 0.001) and **MRI (p < 0.001) were 
significantly lower in the neonates that died (Kruskal-Wallis test) than in neonates surviving 
without epilepsy or those lost to follow-up. Post-hoc comparisons showed no difference to 
those developing with epilepsy. ***p < 0.05 Apgar scores were significantly lower in the 
neonates that died (Kruskal-Wallis test) than in neonates of the other groups. FU = follow-up, 
TH = therapeutic hypothermia, GA = gestational age, SEP = somatosensory evoked potential. 
a = not available for two neonates, b = not available for one neonate. 






No epilepsy  
n=68 
Lost to FU 
n=6 
Females 44 (48%) 5 (42%) 3 (50%) 34 (50%) 2 (33%) 
Received TH 76 (83%) 10 (83%) 6 (100%) 54 (79%) 6 (100%) 
GA (weeks) 39.6 [1.7] 39.8 [1.7] 40.3 [1.0] 39.6 [1.7] 39.5 [1.9] 
Postmenstrual age at EEG-
SEP (weeks) 
40.1 [1.6] 40.0 [1.6] 40.6 [1.0] 40.1 [1.7] 40.0 [1.9] 
Postnatal age at EEG-SEP (h) 81.5 {58} 40 {22}* 35.5 {78} 87 {52} 94 {33} 
Postmenstrual age at MRI 
(weeks) 
40.3 [1.7] 40.1 [1.7] 41.0 [1.0] 40.3 [1.7] 40.4 [2.2] 
Postnatal age at MRI (h) 108 {61} 54.5 {21}** 99 {135} 112 {67} 138 {51} 
Birth weight (g)  3400 [620]  3340 [550] 3340 [630] 3390 [620]a 3670 [890]b 
Base excess -13.0 [6.4] -13.2 [11.4] -13.5 [5.6]b -13.0 [5.5] -11.70 [4.2]b 
pH 7.02 [0.17] 7.02 [0.25] 7.05 [0.13] 7.01 [0.16] 7.06 [0.14]b 
Apgar 1 min 1 {3} 0 {1}*** 3 {3} 1{2}a 2{2}b 
Apgar 5 min 3 {3} 0 {1}*** 3 {5} 3{3}a 3{3}b 





Table 2. Neurophysiological and MRI findings according to hypoxic-ischemic 
encephalopathy (HIE) severity and outcome. 
 
Data shown as n. 
FU = follow-up, Epi = epilepsy, Gr = grade, IS = infantile spasms syndrome, SEP = 
somatosensory evoked potential.  




 Table 2. HIE 3 
Total 












FU   
 n 26 12 5 1 6 2 66 62 4 
EEG Gr4 14 10 3 1 - - 0 - - 
 Gr3 8 2 2 - 4 - 10 10 - 
 Gr2-0 4 - - - 2 2 56 52 4 
SEP 
(n=88*) 
Bilaterally absent 18 10 5 1 2 - 0 - - 
Unilaterally absent 1 1 - - - - 1 1 - 
 Present 6 1 - - 4 1 62 58 4 
MRI 3 8 5 2 1 - - - - - 
 2B 11 6 3 - 2 - 6 6 - 





Table 3. The sensitivity, specificity, positive (PPV) and negative predictive values (NPV) with 95% confidence intervals of different 
clinical, neurophysiological and neuroimaging parameters and their combinations for predicting the development of epilepsy (infantile 





Accuracy Specificity Sensitivity PPV NPV 
HIE III 12 5 1 92 [83-97] 91 [82-97] 100 [54-100] 50 [32-68] 100 [-] 
MRI 3 3 2 1 96 [89-99] 100 [95-100] 50 [12-88] 100 [-] 96 [91-98] 
MRI 2B/3 14 5 1 89 [80-95] 88 [78-95] 100 [54-100] 43 [28-59] 100 [-] 
EEG gr4 4 3 1 97 [91-100] 100 [95-100] 67 [22-96] 100 [-] 97 [92-99] 
EEG gr3-4 16 5 1 86 [77-93] 85 [75-93] 100 [54-100] 38 [25-52] 100 [-] 
SEP* bilaterally absent  
(all HIE III and EEG gr3-4) 
8 5 1 97 [90-100] 97 [89-100] 100 [54-100] 75 [43-92] 100 [-] 
HIE III & MRI 2B/3 8 5 1 97 [91-100] 97 [90-100] 100 [54-100] 75 [43-92] 100 [-] 
HIE III & EEG gr3-4 10 5 1 95 [87-99] 94 [86 98] 100 [54-100] 60 [37-80] 100 [-] 
MRI 2B/3 & SEP -/- (n=71) 7 5 1 99 [92-100] 98 [92-100] 100 [54-100] 86 [46-98] 100 [-] 
Gr = grade, HIE = hypoxic-ischemic encephalopathy, SEP-/- = bilaterally absent somatosensory evoked potentials 






Table 4. Details of the neurophysiological and neuroimaging findings of the patients with severe hypoxic ischemic encephalopathy (HIE). 
 




MRI Post-natal age 
at MRI [h] 
Outcome 
epilepsy 
Outcome other Age at follow-
up (mo) 
1 4 - 81 PBT 3 83 IS Dyskinetic CP (GMFCS V, CFCS V) 23 
2 4 -     27 PBT, LEV 2B 35 IS Spastic tetraplegic CP (GMFCS V, CFCS IV)  27 
3 4 - 11 - 3 297 IS Diplegic CP (GMFCS IV, CFCS IV) 25 
4 3 -     44 (PBT), FEN 2B 115 IS Severe CP (GMFCS V, CFCS IV-V) 21 
5 4 -     23 (PBT), LEV, FEN 3 54 Epilepsy Spastic tetraplegic CP (GMFCS V, CFCS IV-V) 28 
6 3 -     149 (PBT) 2B 147 IS Severe CP (GMFCS V, CFCS V)  30 
7 2 + 56 PBT, LEV, MID, FEN 1B  91 No Normal 12 
8 3 + 104 PBT, FEN, DEX 2B 84 No Spastic diplegic CP (GMFCS IV, CFCS IV) 27 
9 3 - 85 PBT, LEV, MID, FEN 2B* 88 No Spastic diplegic CP (GMFCS III, CFCS IV) 23 
10 1 + 185 (PBT), FEN 1A** 383 No Mild delay in motor skills 24 
11 3 -     83 (PBT), MO 2A 130 No Moderate dyskinetic CP (GMFCS II) 24 
12 3 + 50 PBT, LEV, MID, FEN 2A 101 No Spastic hemiplegic CP l.sin. (GMFCS I, CFCS III) 24 
CNS = central nervous system, CP = cerebral palsy, SEP - / + = somatosensory evoked potentials absent / present, PBT = phenobarbital, (PBT) = 
loading dose of phenobarbital > 8 hours prior to EEG, FEN = phenytoin, MID = midazolam, LEV = levetiracetam, DEX = dexmedetomidine, 
MO = morphin, GMFCS = Gross Motor Function Classification System, CFCS = Communication Function Classification System. *In addition, 
right parietal epidural hemorrhage **Small hemorrhage in right caudothalamic sulcus and ventricle. 
